Bio Green Med Solution Statistics
Bio Green Med Solution (UXI1) Stock Statistics & Valuation Metrics
Total Valuation
Bio Green Med Solution has a market cap or net worth of EUR 3.85M. The enterprise value is EUR 2.39M.
- Market Cap
- EUR 3.85M
- Enterprise Value
- EUR 2.39M
Share Statistics
Bio Green Med Solution has 6,622,794 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 6,622,794
- Owned by Insiders
- ―
- Owned by Institutions
- 0.09%
Financial Efficiency
Bio Green Med Solution’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -122.97%.
- Return on Equity (ROE)
- -0.44
- Return on Assets (ROA)
- -0.37
- Return on Invested Capital (ROIC)
- -122.97%
- Return on Capital Employed (ROCE)
- -1.23
- Revenue Per Employee
- 62.25K
- Profits Per Employee
- -249.83K
- Employee Count
- 12
- Asset Turnover
- 0.09
- Inventory Turnover
- 0.44
Valuation Ratios
The current PE Ratio of Bio Green Med Solution is -0.27. Bio Green Med Solution’s PEG ratio is -0.00.
- PE Ratio
- -0.27
- PS Ratio
- 1.58
- PB Ratio
- 0.64
- Price to FCF
- -3.72
- Price to Operating Cash Flow
- -4.46
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Bio Green Med Solution had revenue of 747.00K and earned -3.00M in profits. Earnings per share was -6.45.
- Revenue
- 747.00K
- Gross Profit
- 138.00K
- Operating Income
- -8.43M
- Pretax Income
- -2.99M
- Net Income
- -3.00M
- EBITDA
- -8.42M
- Earnings Per Share (EPS)
- -6.45
Cash Flow
In the last 12 months, operating cash flow was -950.00K and capital expenditures -1,000, giving a free cash flow of -951.00K billion.
- Operating Cash Flow
- -950.00K
- Free Cash Flow
- -951.00K
- Free Cash Flow per Share
- -0.14
Dividends & Yields
Bio Green Med Solution pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -26.91%
- Earnings Yield
- -39.19%
Stock Price Statistics
- Beta
- -0.09
- 52-Week Price Change
- -37.25%
- 50-Day Moving Average
- 1.36
- 200-Day Moving Average
- 1.45
- Relative Strength Index (RSI)
- 0.00
- Average Volume (3m)
- ―
Important Dates
Bio Green Med Solution upcoming earnings date is Apr 06, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 12, 2026
- Next Earnings Date
- Apr 06, 2027
- Ex-Dividend Date
- ―
Financial Position
Bio Green Med Solution as a current ratio of 4.70, with Debt / Equity ratio of 0.03%
- Current Ratio
- 4.70
- Quick Ratio
- 3.66
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.42
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Bio Green Med Solution has paid 7,000 in taxes.
- Income Tax
- 7,000
- Effective Tax Rate
- -0.00
Enterprise Valuation
Bio Green Med Solution EV to EBITDA ratio is -0.04, with an EV/FCF ratio of -0.08.
- EV to Sales
- 0.04
- EV to EBITDA
- -0.04
- EV to Free Cash Flow
- -0.08
- EV to Operating Cash Flow
- -0.08
Balance Sheet
Bio Green Med Solution has EUR 3.45M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 3.45M billion.
- Cash & Marketable Securities
- EUR 3.45M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 3.45M
- Net Cash Per Share
- EUR 0.52
- Tangible Book Value Per Share
- EUR 0.77
Margins
Gross margin is 20.50%, with operating margin of -101.43%, and net profit margin of -74.40%.
- Gross Margin
- 20.50%
- Operating Margin
- -101.43%
- Pretax Margin
- -72.29%
- Net Profit Margin
- -74.40%
- EBITDA Margin
- -97.85%
- EBIT Margin
- -98.12%

